Powder: -20°C for 3 years | In solvent: -80°C for 2 years
UNBS-5162 is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 37.00 | |
2 mg | In stock | $ 50.00 | |
5 mg | In stock | $ 72.00 | |
10 mg | In stock | $ 135.00 | |
25 mg | In stock | $ 267.00 | |
50 mg | In stock | $ 447.00 | |
100 mg | In stock | $ 659.00 | |
500 mg | In stock | $ 1,390.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 132.00 |
Description | UNBS-5162 is a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers. |
Synonyms | UNBS 5162, UNBS-5162 |
Molecular Weight | 326.35 |
Formula | C17H18N4O3 |
CAS No. | 956590-23-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
DMSO: 11 mg/mL (33.71 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
UNBS5162 956590-23-1 Autophagy GPCR/G Protein Immunology/Inflammation CXCR UNBS 5162 inhibit Inhibitor CXC chemokine receptors UNBS-5162 inhibitor